Skip to main content

Table 1 Traits passing the PhenoSpD significance threshold (5.43E-5) in the MR-PheWAS of all traits in UK Biobank on DVT risk with the Inverse Variance Weighted (SNP > 1) and Wald Ratio (SNP = 1). Exposures highlighted in orange are referred to as "adiposity-related" in the main text

From: A phenome-wide approach to identify causal risk factors for deep vein thrombosis

Exposure

No. SNP

MR method

Log Risk Ratio*

CI (95%)

SE

P-value

PHet (ML)

PPlt

Treatment/medication code: warfarin

7

IVW

4.29

3.09

5.49

0.61

1.40E-09

5.66E-40

0.4260

Mania/bipolar disorder/manic depression

1

WR

3.95

2.60

5.30

0.69

5.18E-06

NA

NA

Chronic obstructive airways disease/copd

1

WR

3.72

1.39

4.37

0.76

9.21E-07

NA

NA

Treatment/medication code: carbimazole

9

IVW

3.60

2.70

4.50

0.46

2.41E-12

5.21E-01

0.1048

Varicose veins

2

IVW

3.40

2.31

4.49

0.56

5.13E-07

4.42E-01

NA

Hyperthyroidism/thyrotoxicosis

6

IVW

2.39

1.88

2.90

0.26

8.69E-18

6.69E-01

0.3874

Varicose veins of lower extremities

16

IVW

1.90

1.30

2.50

0.31

2.36E-07

1.91E-01

0.5039

Lysine

1

WR

1.50

0.61

1.96

0.34

1.25E-05

NA

NA

Prospective memory result

2

IVW

1.46

1.02

1.90

0.23

5.33E-08

4.61E-01

NA

Long-standing illness disability or infirmity

14

IVW

1.25

0.87

1.63

0.20

8.13E-08

2.17E-01

0.4463

Taking other prescription medications

10

IVW

1.17

0.79

1.55

0.20

1.36E-06

4.83E-01

0.4399

Eicosapentaenoate (EPA; 20:5n3)

1

WR

1.10

0.75

1.45

0.18

3.14E-07

NA

NA

Stearidonate (18:4n3)

1

WR

1.09

0.73

1.45

0.18

1.22E-06

NA

NA

Docosapentaenoate (n3 DPA; 22:5n3)

1

WR

1.08

0.47

1.46

0.25

2.01E-05

NA

NA

Adrenate (22:4n6)

1

WR

1.01

0.55

1.32

0.20

3.48E-07

NA

NA

X-14473

1

WR

1.01

0.48

1.35

0.22

5.14E-06

NA

NA

Qualifications: None of the above

64

IVW

0.99

0.72

1.26

0.14

2.03E-10

6.18E-01

0.0335

Arachidonate (20:4n6)

1

WR

0.91

0.61

1.22

0.16

2.08E-06

NA

NA

Overall health rating

54

IVW

0.80

0.61

0.99

0.10

4.40E-14

5.14E-01

0.6398

Leg fat percentage (right)

246

IVW

0.59

0.47

0.71

0.06

3.32E-18

2.87E-03

0.2399

Comparative body size at age 10

157

IVW

0.57

0.46

0.68

0.06

3.98E-22

5.18E-01

0.1954

Arm fat percentage (right)

234

IVW

0.55

0.42

0.68

0.07

8.48E-14

8.47E-17

0.6940

Arm fat percentage (left)

253

IVW

0.55

0.41

0.68

0.07

1.61E-12

1.32E-24

0.6983

Leg fat percentage (left)

248

IVW

0.54

0.40

0.67

0.07

1.76E-12

7.00E-04

0.7261

Leg fat mass (right)

282

IVW

0.53

0.44

0.62

0.05

4.23E-28

9.07E-03

0.4978

Leg predicted mass (right)

361

IVW

0.52

0.43

0.60

0.04

8.79E-29

1.34E-02

0.6652

Leg predicted mass (left)

356

IVW

0.52

0.43

0.60

0.05

2.99E-27

5.18E-03

0.8052

Body fat percentage

253

IVW

0.51

0.41

0.61

0.05

1.48E-20

4.79E-02

0.6346

Leg fat-free mass (left)

361

IVW

0.51

0.42

0.60

0.05

6.10E-27

4.73E-03

0.8069

Leg fat-free mass (right)

363

IVW

0.50

0.41

0.59

0.05

1.11E-25

5.05E-03

0.5560

Waist circumference

227

IVW

0.50

0.40

0.59

0.05

1.74E-22

1.65E-02

0.5222

Leg fat mass (left)

281

IVW

0.50

0.40

0.59

0.05

1.85E-23

3.71E-02

0.5530

Weight

337

IVW

0.46

0.38

0.54

0.04

1.93E-28

1.33E-03

0.8573

Arm fat mass (right)

270

IVW

0.45

0.38

0.52

0.04

1.06E-30

3.60E-01

0.2818

Arm fat mass (left)

268

IVW

0.45

0.38

0.53

0.04

4.98E-29

1.93E-01

0.1348

Basal metabolic rate

377

IVW

0.45

0.36

0.54

0.05

2.62E-20

3.71E-03

0.7064

Arm predicted mass (left)

349

IVW

0.45

0.34

0.55

0.05

3.37E-14

1.53E-05

0.2577

Trunk fat percentage

237

IVW

0.44

0.35

0.54

0.05

2.91E-16

2.43E-03

0.6180

Whole body fat mass

280

IVW

0.44

0.36

0.51

0.04

4.65E-27

1.75E-01

0.1772

Arm fat-free mass (right)

350

IVW

0.44

0.33

0.54

0.05

1.66E-13

2.95E-04

0.2180

Arm predicted mass (right)

364

IVW

0.43

0.32

0.54

0.05

6.96E-13

9.35E-05

0.2660

Trunk fat mass

283

IVW

0.43

0.35

0.51

0.04

1.73E-23

2.90E-03

0.6360

Arm fat-free mass (left)

355

IVW

0.42

0.32

0.53

0.05

1.84E-12

3.14E-05

0.1920

Whole body water mass

405

IVW

0.42

0.32

0.51

0.05

7.67E-15

1.32E-04

0.3436

Whole body fat-free mass

405

IVW

0.41

0.31

0.50

0.05

3.90E-14

2.06E-04

0.3422

Body mass index (BMI)

305

IVW

0.40

0.32

0.47

0.04

1.60E-22

6.81E-02

0.5286

Trunk fat-free mass

406

IVW

0.39

0.29

0.48

0.05

2.32E-11

2.46E-06

0.0575

Trunk predicted mass

406

IVW

0.38

0.28

0.48

0.05

4.10E-11

9.09E-06

0.0513

Hip circumference

282

IVW

0.36

0.28

0.45

0.04

2.22E-13

2.92E-04

0.0876

Comparative height size at age 10

364

IVW

0.30

0.20

0.40

0.05

1.93E-06

1.56E-05

0.1080

Overweight

14

IVW

0.28

0.18

0.38

0.05

3.07E-05

3.44E-01

0.1711

Obesity class 1

17

IVW

0.18

0.11

0.25

0.03

1.34E-07

7.33E-01

0.2392

Standing height

591

IVW

0.17

0.09

0.24

0.04

4.61E-06

3.14E-05

0.1018

Obesity class 2

11

IVW

0.17

0.11

0.22

0.03

2.79E-06

5.45E-01

0.6859

Height

367

IVW

0.15

0.08

0.21

0.03

5.92E-06

1.58E-03

0.3372

Impedance of leg (right)

319

IVW

-0.55

-0.80

-0.35

0.12

2.21E-06

4.23E-06

0.0003

Impedance of leg (left)

323

IVW

-0.69

-1.05

-0.43

0.16

1.00E-05

9.96E-21

0.0072

  1. *Methods: Inverse Variance Weighted (SNP > 1) and Wald Ratio (SNP = 1)
  2. *LogRiskRatio is the logged value of the beta coefficient of the MR analysis into risk ratios. It can be read as an increase in the LogRisk of DVT per unit increase in trait
  3. *PHET ML is the P-value of the Maximum Likelihood analysis looking at heterogeneity between genetic variants used to instrument a trait. H0 is that there is no heterogeneity present
  4. *PPlt is the P-value of the MR-Egger analysis looking at the presence of horizontal pleiotropy. H0 is that there is no pleiotropy present